The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
Cells | Free Full-Text | Estrogen-Receptor Expression and Function in Female Reproductive Disease
Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of Medicinal Chemistry
Dual-mechanism estrogen receptor inhibitors | PNAS
Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase | PLOS ONE
Contribution of ER and NF-κB to endocrine resistance in inflammatory breast cancer | Breast Cancer Management
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)
Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
IJMS | Free Full-Text | Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers
Expression of receptor activator of NFkB (RANK) drives stemness and resistance to therapy in ER+HER2- breast cancer | Oncotarget
Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase | PLOS ONE
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
The interaction between ER and NFκB in resistance to endocrine therapy | Breast Cancer Research | Full Text
IJMS | Free Full-Text | Emerging Roles of Estrogen-Regulated Enhancer and Long Non-Coding RNAs
IJMS | Free Full-Text | Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers
Frontiers | G Protein-Coupled Estrogen Receptor, GPER1, Offers a Novel Target for the Treatment of Digestive Diseases
Transrepression of estrogen receptor and NFκB. (a) NFκB can inhibit... | Download Scientific Diagram
Estrogen receptor-α signaling in post-natal mammary development and breast cancers | SpringerLink
View of Novel Breast Cancer Treatment by Targeting Estrogen Receptor-Alpha Stability Using Proteolysis-Targeting Chimeras (PROTACs) Technology | Exon Publications
Dynamic transcriptional events mediated by estrogen receptor alpha
Estrogen-induced immune changes within the normal mammary gland | Scientific Reports
Effect of the pure ER antagonist fulvestrant on the estrogen stimulated... | Download Scientific Diagram
